Abiopharma

🔍 Fesko John (Executive)

Company: Natera, Inc. (NTRA)

Report Date: 2026-04-27

Detailed Transactions and Holdings:

• Sold 771 shares of Common Stock at $203.75 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 188,428.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 917 shares of Common Stock at $204.39 per share (Direct)
  Date: 2026-04-27 | Code: S | equity_swap_involved: 0 | shares_owned_after: 187,511.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of Restricted Stock Units ("RSUs") and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 26, 2024.
• F2: The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and was made pursuant to a written instruction that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act contained in the Reporting Person's Stock Unit Agreement granted on January 27, 2023.